These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2310058)

  • 21. Inverse relation between peak expiratory flow rate (PEFR) and duration of attacks in asthmatics undergoing therapy with Ketotifen.
    Baskaranathan S; Powar JS; Bisseru B
    Med J Zambia; 1984 Jan; 18(1):15-8. PubMed ID: 6398565
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical spectrum and patterns of air-flow obstruction in bronchial asthma amongst adult Indians.
    Bhasin RC; Dhawan J
    Indian J Chest Dis Allied Sci; 1984; 26(1):13-9. PubMed ID: 6510981
    [No Abstract]   [Full Text] [Related]  

  • 23. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of peak expiratory flow rate to predict hospital admission in acute asthma.
    Martin TG; Elenbaas RM; Pingleton SH
    Ann Emerg Med; 1982 Sep; 11(9):466-70. PubMed ID: 7114591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The accuracy of several brands of portable peak flow meter, and the predicted value of peak expiratory flow rate for children].
    Takamasu T; Kurihara K
    Nihon Rinsho; 1996 Nov; 54(11):2933-8. PubMed ID: 8950933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma in children.
    Simon PA; Murphy CM; Coonce SL
    Clin Pharm; 1992 May; 11(5):386-7. PubMed ID: 1582130
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma.
    Bellia V; Cibella F; Coppola P; Greco V; Insalaco G; Milone F; Oddo S; Peralta G
    Respiration; 1984; 46(3):328-33. PubMed ID: 6494629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of discontinuing peak flow monitoring in stable asthma].
    Hasegawa T; Nishimura T; Ishihara K; Takakura S; Okazaki M; Katakami N; Umeda B
    Nihon Kokyuki Gakkai Zasshi; 2000 Aug; 38(8):581-4. PubMed ID: 11061081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and prognostic value of morning dipping of peak expiratory flow rate in stable asthmatic subjects.
    Bellia V; Cibella F; Migliara G; Peralta G; Bonsignore G
    Chest; 1985 Jul; 88(1):89-93. PubMed ID: 4006561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of walking on peak expiratory flow rate in four asthmatic children.
    Karper WB
    Percept Mot Skills; 1988 Dec; 67(3):847-52. PubMed ID: 3226836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective comparative study of in-hospital management of acute severe asthma: 1984 vs 1989.
    Kuo E; Kesten S
    Chest; 1993 Jun; 103(6):1655-61. PubMed ID: 8404081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home monitoring of asthma with peak expiratory flow rates.
    Twarog FJ
    Ann Allergy; 1991 Nov; 67(5):457-60. PubMed ID: 1957998
    [No Abstract]   [Full Text] [Related]  

  • 33. Home-monitoring of peak expiratory flow rate using mini-Wright peak flow meter in diagnosis of asthma.
    Prior JG; Cochrane GM
    J R Soc Med; 1980 Oct; 73(10):731-3. PubMed ID: 7241425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting future risk of asthma exacerbations using individual conditional probabilities.
    Thamrin C; Zindel J; Nydegger R; Reddel HK; Chanez P; Wenzel SE; FitzPatrick S; Watt RA; Suki B; Frey U
    J Allergy Clin Immunol; 2011 Jun; 127(6):1494-502.e3. PubMed ID: 21333347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma.
    Nowak RM; Pensler MI; Sarkar DD; Anderson JA; Kvale PA; Ortiz AE; Tomlanovich MC
    Ann Emerg Med; 1982 Feb; 11(2):64-9. PubMed ID: 7137687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using statistical process control charts for the continual improvement of asthma care.
    Boggs PB; Hayati F; Washburne WF; Wheeler DA
    Jt Comm J Qual Improv; 1999 Apr; 25(4):163-81. PubMed ID: 10228909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One month chronocorticotherapy (Dutimelan 8 15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration.
    Reinberg A; Guillet P; Gervais P; Ghata J; Vignaud D; Abulker C
    Chronobiologia; 1977; 4(4):295-312. PubMed ID: 614119
    [No Abstract]   [Full Text] [Related]  

  • 38. [Value of measurement of peak flow (peak expiratory flow rate Vmx50) in epidemiological surveys in chronic bronchitis].
    Dutu S; Jienescu Z
    Bronches; 1975; 25(2):148-51. PubMed ID: 1220841
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicting asthma exacerbations: peak expiratory flow revisited.
    Fuhlbrigge AL
    J Allergy Clin Immunol; 2011 Jun; 127(6):1503-4. PubMed ID: 21536320
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma.
    Martin TG; Elenbaas RM; Pingleton SH
    Ann Emerg Med; 1982 Feb; 11(2):70-3. PubMed ID: 6814315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.